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Abstract  
Periods of short-term intensified training (IT) are often used by athletes during training cycles over 
the season and undergoing phases of increased physical stress may impact upon the immune 
system.  This study investigated the effects of a period of IT on free light chains (FLCs) in saliva - 
an emerging immune biomarker of oral inflammation - and matched serum samples in well-trained 
athletes.  It also examined if IT influences basal FLC levels and FLC flux during acute exercise.  
Highly trained male cyclists (n = 10) underwent a 9-day period of IT; before and after IT 
participants performed a 1 h time trial (TT) on a cycle ergometer, with blood and saliva samples 
collected pre- and post-exercise.  FLCs were assessed in serum and saliva, and IgG, IgA, IgM and 
creatinine were also measured in serum.  Weekly training volume increased by 143% (95% CI 
114–172%), p < 0.001, during IT compared with pre-trial baseline training.  Following IT, the 
cyclists demonstrated higher salivary FLC levels.  Both salivary lambda FLC concentrations (p < 
0.05, η2 = .384) and secretion rates, and kappa FLC concentrations and secretion rates increased 
after IT.  Salivary FLCs concentration and secretion rates decreased in response to the TT 
following IT (p < 0.05, η2 = .387–.428), but not in response to the TT prior to IT.  No significant 
effects of IT on serum FLCs were observed.  There were no significant changes in serum FLCs in 
response to the TT, before or after the IT period, nor did IT impact upon other serological 
responses to the TT.  In conclusion, IT increased basal salivary FLC parameters and amplified 
decreases in salivary FLCs in response to acute exercise.  Increases in salivary FLC concentration 
likely reflects alterations to oral inflammation during times of heavy training, and we show for the 
first time that FLCs may have utility as a marker of exercise stress and oral health status.  
 
Key words: free light chains, saliva, exercise, training, athletes, inflammation  
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1. Introduction 
Periods of short-term intensified training (IT) or over-reaching are often used by athletes during 
training cycles over the course of a season to elicit performance gains.  Whilst IT may improve an 
athlete’s physiological and performance capacities, it is thought that there may be detrimental 
consequences to host health. Perturbations to several aspects of cellular and mucosal immunity 
have been reported following short-term (1–3 weeks) IT in trained athletes [1, 2]. It is speculated 
that immune changes may compromise host defence and lead to a heightened risk of upper 
respiratory tract infections (URTI).  Salivary IgA (sIgA) has been associated with the incidence of 
URTI in athletes and progressive decreases in sIgA have been observed during periods of  IT [2].  
However, strong evidence of the link between exercise, oral immunity and susceptibility to 
infections is still lacking.  Surprisingly, an aspect of immune competency that has received little 
attention are immune biomarkers of oral inflammation. Indeed, athletes have been shown to have 
particularly poor oral health [3].  Athletes attending the Dental Clinic of the 2012 Olympic Games 
presented with high rates of periodontal disease [4].  Poor oral health has been negatively 
associated with self-reported performance leading to recommendations for greater consideration of 
this factor for optimal performance for elite athletes [3-5].  However, to what extent short-term 
periods of intensive training affect oral inflammation in athletes is not well characterised.  
Identification of biomarkers to monitor ‘exercise stress’ may be of utility in high-performance sport 
for detecting those at risk of performance deficiency or adverse well-being and health effects.   
Immunoglobulin free light chains (FLCs) have recently been quantified for the first time in human 
saliva and are considered an emerging biomarker of oral inflammation [6].  Light chains are 
produced by plasma cells in excess of heavy chains, meaning that for every intact immunoglobulin 
– comprised of two identical heavy chains and two identical light chains – that is produced, there is 
abundant light chain (FLC) secreted by plasma cells into the systemic circulation [7].  Serum FLCs 
and the ratio of kappa:lambda light chains (Κ:λ ratio) are central in the diagnosis, prognosis and 
monitoring of plasma cell malignancies, such as multiple myeloma, where serum FLC analysis is 
recommended internationally for measurement of involved FLC from monoclonal plasma cells [8-
11].  FLCs are also dysregulated in a range of non-malignant disorders.  For example, elevated 
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polyclonal FLCs have been observed in a range of conditions including: rheumatoid arthritis, 
multiple sclerosis, systemic lupus erythematosus, heart failure, diabetes, renal disease, asthma, 
chronic obstructive pulmonary disease, inflammatory bowel disease and HIV infection [12-14].  In 
these conditions FLCs are useful as a marker of disease activity and for predicting disease 
progression.  In the general population, combined levels of kappa and lambda FLCs (FLC sum) 
have been shown to be prognostic for all-cause mortality, whereby FLC sum negatively predicted 
survival in a large cohort of individuals aged ≥ 50 years without plasma cell disorders [15].  Using a 
method of sensitive quantitation for FLCs in saliva, we found that substantially higher levels of 
salivary FLCs are present in elderly individuals compared with younger adults, indicative of poorer 
overall oral health and a greater degree of local inflammation and immune activation in this age 
group [6].  
To date, the impact of short-term changes in exercise training load on FLC levels in saliva or 
serum has yet to be investigated.  There is evidence to suggest that FLCs in both saliva and blood 
could be affected by changes to training loads, whereby increases in training load may negatively 
impact upon oral health or disrupt local immune and inflammatory processes that may translate 
into perturbations in salivary FLCs.  Decreases in B cells have been shown in athletes after an 
intense training camp [16], which in turn could result in reductions in FLC levels.  Furthermore, 
undergoing a period of increased physical stress could impact upon how the immune system 
responds to an acute exercise challenge.  The effects of acute exercise on salivary FLC 
concentration and secretion rates appear dependent on age; significant reductions in salivary FLCs 
have been observed post-exercise in elderly adults, where only modest reductions occurred in 
young adults [6].  Kappa FLCs were found to be only marginally elevated in runners following a 
marathon compared with pre-exercise levels, thought to be indicative of perturbations to renal 
function proportional to exercise intensity [17].  Consistent with this, other studies of lower exercise 
intensity have found no changes in serum FLCs in response to exercise [6, 18].  One study 
investigated the effects of IT on immune responses to acute exercise and generally found no 
changes based on increased training load [19].  However, to our knowledge very few other studies 
have since investigated this and the effects of IT on FLC responses to acute exercise have not 
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been explored.  The primary aim of the present study was to assess the effects of a period of IT on 
FLCs in saliva and serum in well-trained athletes, and secondly, to examine if IT influences FLC 
responses to acute exercise.   
 
2. Materials and Methods 
2.1. Participants  
Highly trained male cyclists (n = 10) with a competitive cycling background of at least 3 years, 
cycling ≥ 3 times per week for a minimum of 2 h per day, participate in this study.  Participants had 
a mean ± SD age of 23.6 ± 4.0 years; BMI of 21.6 ± 1.5 kg/m2; VO2max of 72.7 ± 4.8 mL/kg/min.  
Inclusion criteria stipulated that participants were not suffering from any acute illness in the two 
weeks prior to, or during the study and they had no chronic illness, history of chronic illness, nor 
were taking any medications.  Informed consent was obtained from all individual participants 
included in the study.  
2.2. Study design  
Participants underwent pre-study testing to confirm suitability to take part in the study.  After 
enrolment into the study, participants’ exercise performance was assessed before and after a 
period of IT [20]. Participants performed a 1 h time trial on a cycling ergometer, with blood and 
saliva samples collected pre- and post-exercise; then underwent a 9-day period of IT cycling; 
participants then performed another 1 h TT with blood and saliva samples collected pre- and post-
exercise.  
2.3. Pre-study testing and familiarisation 
Participants visited the laboratory for pre-trial exercise testing to confirm individuals were highly 
trained (VO2max of ≥ 65 mL/kg/min) and therefore suitable to be included in the study.  During this 
visit, participants performed an incremental cycle test to exhaustion on an electronically braked 
ergometer (Lode Excalibur Sport, Groningen, Netherlands) to assess VO2max.  Expiratory gases 
were collected continually throughout the test and breath-by-breath analysis was performed 
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automatically with a Moxus metabolic systems analyser (AEI Technologies Inc., Naperville, IL, 
USA).  Heart rate (HR) was recorded continually using short range telemetry (Polar RS800CX, 
Polar, Kempele, Finland) and ratings of perceived exertion were recorded from participants during 
the final minute of each stage.  Suitable participants then recorded a 2-week training diary, were 
provided with a HR monitor (Suunto ANT, Amer Sports Corporation, Finland) and a SRM power 
meter (SRM Shimano DA7900 PowerMeter) to monitor their training.  Participants were also 
requested to train according to their normal programmes during this phase.  Following the pre-trial 
phase, participants began 9 days of IT.  
2.4. Intensified Training 
Individual IT programmes were based on participants’ pre-trial training diaries and discussed with 
each individual athlete.  Training volume and intensity defined by HR (time spent in the highest 3 
HR zones) was increased 2.5-fold from baseline.  HR zones were calculated from maximum HR 
achieved during the pre-study VO2max test.  Five zones were devised, and expressed as a 
percentage of maximum HR; Zone 1: <69 %, Zone 2: 69 %–81 %, Zone 3: 82 %–87 %, Zone 4: 
88% –94 %, Zone 5: >94 % [21].  Power zones were also applied to interval sessions: these were 
calculated as a percentage of peak power (W) attained in each participant’s VO2max test and used 
as a guideline during training sessions, alongside HR.  We expected the IT would reduce a 
participant's ability to achieve the same distribution of HR zones; therefore, power zones were put 
in place as an additional measure to encourage participants to achieve the highest workload 
possible.  Participants uploaded data files (power and HR) after each training session via secure 
online training software (Training Peaks, Boulder, CO, USA.).  This process enabled the 
researchers to monitor sessions not performed in the laboratory. 
 
2.5. Time Trials 
Participants arrived at the laboratory between 06:30-08:30 following an overnight fast of ≥ 8 h. 
Blood samples were collected from an antecubital vein from participants in a seated position.  
Unstimulated saliva samples were collected during a 3-min collection period from participants in 
the seated position.  Following a 10-min warm-up at a self-selected intensity, participants 
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performed an all-out 1-h TT on their own bicycle on a Turbo Trainer (CycleOps Flow, Madison, WI, 
USA) in a quiet laboratory environment at 20 ± 1ºC.  HR was recorded continually throughout each 
TT with short range telemetry (Suunto, Vantaa, Finland).  Participants were blinded from their 
power, cadence and HR during the TT and only provided with a stop clock.  Participants were 
permitted to drink water ad libitum during TT, except for the final 10 min.  Post-TT blood and saliva 
samples were collected within 5 min of exercise cessation.  
 
2.6. Blood and saliva samples 
Blood was collected by venepuncture into plain vacutainer tubes (BD Vacutainer, Plymouth, UK).  
Whole blood samples were allowed to clot at room temperature for 20 min and then centrifuged at 
5,000 g for 10 min at 4°C; separated serum was immediately stored at -20°C until analysis.  
Unstimulated saliva samples were collected with participants in the seated position, leaning 
forward with their head tilted forward.  Participants were asked to swallow to empty their mouth of 
any residual saliva before the timed sample collection began.  Saliva collections lasted 3 min, 
during which time participants were requested to minimise orofacial movement and passively 
dribble into a pre-weighed vial.  Samples were weighed to estimate saliva volume assuming a 
saliva density of 1.00 g/mL; saliva flow rate (mL/min) was determined by dividing the volume of 
saliva by the collection time.  Samples were transferred to Eppendorf tubes and centrifuged at 
10,000 g for 2 min to separate cells and insoluble matter.  The supernatant was then removed and 
stored at –20°C until assay.  
 
2.7. Salivary free light chain assays  
Salivary kappa and lambda FLCs were quantified using highly sensitive sandwich ELISAs 
developed by the Clinical Immunology Service at the University of Birmingham.  These assays use 
monoclonal antibodies (mAbs) that have been extensively characterised and validated previously 
[22].  The microtitre wells were coated with mAbs (Abingdon Health, York, UK) that specifically 
target either human kappa or lambda FLC and thus do not bind light chain in whole 
immunoglobulin.  After a blocking period of 1 h to prevent non-specific binding, standards, controls 
and saliva samples were added to the plate in duplicate. After 1 h incubation, plates were washed 
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to remove any unbound sample.  Kappa or lambda detection antibody labelled with horseradish 
peroxidase was then added to the plate and left to incubate for 1 h. Detection antibodies were 
mAbs specific for kappa or lambda light chains either free or bound, that recognise an epitope 
distinct from the one used to capture the FLCs from saliva (Abingdon Health, York, UK). Plates 
were washed again and substrate solution was added; after 10 min incubation, the reaction was 
stopped and the optical density was measured at 450 nm.  The intra-assay CVs were < 10% and 
inter-assay CVs were < 15%. This assay has been described in more detail previously [6].  
 
2.8. Serum free light chain analysis and other serological parameters  
Serum kappa and lambda FLCs were quantified using a multi-plex bead-based assay using a 
Luminex platform (Bio-plex systems, BioRad Laboratories, California, USA).  This assay was 
developed by the Clinical Immunology Service at the University of Birmingham and uses mAbs 
specific for either kappa or lambda FLC (Abingdon Health Ltd, Oxford, UK) in a competitive 
inhibition format.  Full details for this assay have been described previously [22].  Serum creatinine, 
IgG, IgA and IgM were measured on a Roche Hitachi Modular.  To minimize variation, all Roche 
Hitachi Modular analyses were performed on a single day using the same calibration set-up, 
batches, and user.  Using serum creatinine, renal function was assessed by calculating estimated 
creatinine clearance rates (eCrCl) and estimated glomerular filtration rate (eGFR) using the 
Cockcroft-Gault ([140-age] x mass x 1.23 /serum creatinine) and Modification of Diet in Renal 
Disease (186 x serum creatinine-1.154 x age -0.203 x 0.742 if female) formulae, respectively.  
 
2.9. Free light chain parameters  
A range of FLC parameter outputs were analysed as part of this study.  In addition to absolute 
concentrations of kappa and lambda FLC, the ratio of kappa to lambda FLC (Κ:λ ratio) and the 
difference between kappa and lambda FLC (FLC difference) were examined.  The Κ:λ ratio and 
FLC difference are conventionally used in conditions involving perturbed levels of FLC, such as 
plasma cell disorders [23, 24].  The sum of kappa and lambda FLCs (FLC sum) was also 
investigated as this measure has been employed in the general population as a global indicator of 
health status [15].  In addition to protein concentrations, saliva secretion rates of immunoglobulins 
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are typically reported to reflect the total availability of protein at the oral surface and control for 
hydration status [25].  Secretion rates of FLCs (µg/min) were calculated as saliva flow rate x 
kappa/lambda concentration.  The other parameters (sum, difference and ratio) were also 
expressed in this way to control for any impact of saliva flow rate upon these variables.  
 
2.10. Data analyses  
Analyses were undertaken using IBM SPSS version 21.  One-way repeated measures ANOVA 
were used to assess differences in I) training volume and intensity before IT and during IT; II) 
resting FLCs in serum and saliva and serological parameters in serum before and after IT; III) 
FLCs in serum and saliva and serological parameters between pre- and post-exercise, prior to and 
after IT.  If data were not normally distributed, statistical analysis was performed on the logarithmic 
transformation of the data.  Slight variations in degrees of freedom reflect insufficient serum for 
analysis of all parameters.  Greenhouse-Geisser corrected F values are reported for repeated 
measures analyses and partial η2, a measure of effect size, with guidelines of small (> 0.01), 
medium (> 0.06) and large (> 0.14), is reported throughout.  
 
3. Results 
3.1. Intensified training   
Weekly training volume increased significantly during IT compared with pre-trial baseline training 
(143% increase [95% CI 114 to 172%]: 9.4 ± 2.2 to 22.4 ± 3.9 h/week; p < 0.001). Total time spent 
training during the 9 days of IT was 28.8 ± 5.0 h.  Weekly training intensity increased significantly 
during IT compared with pre-trial baseline training (166% increase [95% CI 43 to 290%]: 2.8 ± 1.3 
to 6.8 ± 4.4 h/week spent training above 82% HRmax; p < 0.05).  Total time spent training above 
82% HRmax during IT was 8.7 ± 5.7 h. 
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3.2. The effects of intensified training on resting salivary free light chains  
Following the period of IT, higher FLC concentrations were observed in the cyclists.  This was 
driven by a significantly higher lambda FLC concentration pre-exercise, compared with pre-
exercise at baseline: F(1,9) = 5.61  p =.042, η2 = .384 (Figure 1).  Also indicated in this Figure are 
higher pre-exercise kappa FLCs after IT, although this increase did not reach statistical 
significance.   There was also a trend for resting saliva kappa and lambda FLC secretion rates to 
increase following the IT period (Figure 2).  The corresponding percentage changes in salivary 
FLC concentrations and secretion rates after IT are illustrated in Figure 3.  In general, other resting 
saliva parameters (sum, difference and ratio) for both concentrations and secretions, increased 
following IT; descriptive statistics before and after IT are shown in Table 1.  
 
Table 1  Mean ± standard deviation salivary and serum free light chain (FLC) responses in young 
male trained cyclists, at rest (pre-exercise) and in response to exercise, before (baseline) and after 
a period of intensified training  
 
* Significant decrease compared to pre-exercise, post-intensified training, p < 0.05 
 
 
 
 Baseline Post-intensified training  
 Pre-exercise Post-exercise Pre-exercise Post-exercise 
Saliva flow rate 
(mL/min)  
 
0.62 ± 0.34 0.52 ± 0.18 0.63 ± 0.37 0.53 ± 0.21 
Saliva concentrations (mg/L) 
 
    
FLC sum  2.50 ± 2.17 1.37 ± 0.91 3.59 ± 2.79 1.91 ± 1.19* 
FLC difference 0.68 ± 0.96 0.14 ± 0.59 0.65 ± 1.46 0.65 ± 0.92 
Κ:λ ratio 2.38 ± 1.22 1.88 ± 1.94 2.65 ± 1.88 2.45 ± 1.83 
Saliva parameters controlling 
for flow rate (µg/min) 
 
    
FLC sum   1.17 ± 0.69 0.65 ± 0.40 1.74 ± 1.06 0.94 ± 0.56* 
FLC difference   0.38 ± 0.44 0.08 ± 0.22 0.47 ± 0.80 0.33 ± 0.44 
Κ:λ ratio 1.47 ± 1.03 0.91 ± 0.70 1.77 ± 1.62 1.30 ± 0.95 
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3.3. The effects of intensified training on resting serum parameters: free light chains, 
immunoglobulins and creatinine  
There was no significant effect of IT on resting pre-exercise serum FLC levels: small mean 
changes of –2.8% (95% CI –11.7 to 6.1%) and –5.8% (95% CI –13.4 to 1.7%) where observed for 
kappa and lambda FLCs, respectively.  These percentage changes were much smaller relative to 
those observed in saliva and showed a decrease rather than an increase (concentrations of serum 
FLCs are contrasted with saliva in Figure 1).  Values for other serum FLC parameters (sum, 
difference and ratio) for are reported in Table 2 and did not change significantly following IT.  In 
general, serum immunoglobulins decreased after IT (Table 2, pre-exercise values).  However, this 
decrease was only significant for IgA, F(1,9) = 6.14  p =.035, η2 = .406.  The mean percentage 
changes in immunoglobulins were equivalent to –4.1% for IgG (95% CI –14.2 to 6%), –6.0% for 
IgA (95% CI –11.8 to –0.1%) and –2.6% for IgM (95% CI –33.2 to 28%). There were no changes in 
serum creatinine levels following IT, eCrCl or eGFR (mean values shown in Table 2).  
 
3.4. Salivary free light chain responses to a 1 h all-out cycling time trial, before and after intensified 
training  
At baseline, prior to the IT period, mean saliva variables generally registered lower post-exercise 
values compared with pre-exercise.  However, these did not translate into significant changes in 
salivary FLC concentrations, FLC secretion rates (Figures 1 and 2, baseline exercise bout) or any 
other saliva variables in response to exercise (Table 1, baseline).  In contrast to baseline, the 
exercise bout after IT resulted in significant decreases in salivary FLCs.  As presented in Figures 1 
and 2, kappa concentration (F(1,9) = 5.68  p =.041, η2 = .387), kappa secretion (F(1,9) = 6.65 p 
=.030, η2 = .425) and lambda secretion (F(1,9) = 6.74  p =.029, η2 = .428) were significantly 
reduced in response to the second TT.  Further, FLC sum (F(1,9) = 7.03  p =.026, η2 = .438), and 
FLC sum adjusted for flow rate (F(1,9) = 8.86  p =.016, η2 = .496) also significantly decreased 
(Table 1).  No other saliva parameters changed significantly in response to exercise. 
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Table 2  Mean ± standard deviation serum free light chains, immunoglobulin, creatinine, estimated 
creatinine clearance rate (eCrCl) and estimated glomerular filtration rate (eGFR) responses in 
young male trained cyclists, at rest (pre-exercise) and in response to exercise, before (baseline) 
and after a period of intensified training 
 
* Significant compared to pre-exercise, p < 0.05 
† Significant compared to pre-exercise at baseline, p < 0.05  
 
 
3.5. Serological responses to a 1 h all-out cycling time trial, before and after intensified training  
As shown in Figure 1, there were no significant changes in serum FLCs in response to the TT, 
before or after the IT period.  There were also no significant changes in FLC sum, difference or 
ratio parameters in response to either bout of exercise (Table 2).  In comparison to saliva 
concentrations the changes in serum FLCs were small; mean percentage changes in responses to 
exercise were up to –120% for saliva and < 12% for serum.  As shown in Table 2, serum 
immunoglobulins increased between pre- and post-TT both at baseline and after IT.  With the 
exception of IgG at baseline (F(1,9) = 9.15  p =.014, η2 = .504), these immunoglobulin increases in 
response to exercise were not significant.  Similarly, serum creatinine increased in response to the 
TT, both before and after IT, but not significantly.  However, the increases in serum creatinine were 
 Baseline Post-intensified training  
 Pre-exercise Post-exercise Pre-exercise Post-exercise 
Serum FLCs (mg/L) 
 
    
FLC sum  23.23 ± 2.85 23.44 ± 4.18 22.26 ± 4.35 23.89 ± 3.90 
FLC difference –2.89 ± 2.23 –2.67 ± 1.82 –2.45 ± 1.77 –3.23 ± 2.14 
Κ:λ ratio 0.79 ± 0.15 0.80 ± 0.12  0.81 ± 0.12  0.77 ± 0.14 
Immunoglobulins (g/L)     
IgG  9.40 ± 1.54  9.90 ± 1.80*  8.96 ± 1.74  9.54 ± 1.75  
IgA  1.86 ± 0.51 1.94 ± 0.54 1.74 ± 0.46† 1.89 ± 0.39  
IgM  1.14 ± 0.38  1.19 ± 0.40  1.03 ± 0.33 1.06 ± 0.32  
Creatinine   (umol/L) 97.00 ± 9.72  105.50 ± 14.12 98.20 ± 11.71 108.33 ± 17.76 
eCrCl (mL/min/1.73m2) 102.01 ± 15.59 94.63 ± 17.83* 101.03 ± 15.94 92.55 ± 17.42* 
eGFR (mL/min/1.73m2) 89.21 ± 10.24 81.67 ± 12.40* 88.45 ± 12.57 79.62 ± 15.00* 
12 
 
sufficient enough to significantly decrease eCrCl and eGFR post-exercise both before (F(1,9) = 
27.81 p = 0.001 , η2 = .755 and F(1,9) = 28.22  p < 0.001, η2 = .758, respectively) and after IT 
(F(1,8) = 12.54 p = 0.008 , η2 = .610 and F(1,8) = 11.57  p = 0.010, η2 = .589, respectively).  
 
4. Discussion  
The results of the present study demonstrated that a period of 9-days of IT increased the 
concentration of resting salivary FLCs in trained cyclists.  Significantly higher lambda FLC 
concentrations were found and elevations in other parameters, lambda concentration, kappa and 
lambda secretion rates, and FLC sum, difference and ratio (with and without controlling for flow 
rate) were also observed.  Although all parameters showed the same pattern of elevation, changes 
in concentrations were not consistent, statistical significance was not consistent, most likely 
reflecting the modest sample size of the study; it is likely that more uniform changes would have 
been observed for all of these parameters with a larger sample size, though further studies are 
now warranted to confirm this.  Minimal changes were observed in serum FLCs, suggesting the 
effects of IT on FLCs are isolated to the oral mucosa rather than systemic bloodstream.  
The exact route of FLC entry into saliva has yet to be confirmed but is likely a combination of direct 
gingival passive transfer from blood and local production from plasma cells.  Thus, IT may increase 
localised production of FLCs or alternatively may promote transport of FLCs into the saliva, 
possibly due to changes in oral tissues.  Indeed, FLCs may enter the saliva via gingival crevicular 
fluid (GCF), an oral fluid that consists of serum transudate and tissue exudates and has been 
shown to include immunoglobulins [26-28].  The volume and flow of GCF increases during 
inflammation [29], mainly due to increased vascular permeability [30], and is an indicator of 
gingivitis and periodontitis [27].  Further, increases in inflammatory markers in GCF with gingivitis 
have been seen previously [31].  Due to the role of FLCs in immune and inflammatory processes, 
the observed increases in saliva may represent greater oral inflammation and immune activation, 
and thus potentially increased FLC influx into the saliva through GCF, following increased training 
load.  This could be due to deterioration in oral health during periods of IT.  Athletes have been 
shown in general to have poor oral health and Olympic athletes have been found to have a high 
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incidence of periodontal disease, with the majority (75%) of individuals presenting with gingivitis 
and 15% periodontitis [3, 4]; these rates are above what has been reported in the general 
population in the US and UK  [32, 33].  The physical stress of increasing training load may directly 
affect oral health or indirectly through changes in oral hygiene practices, sleep or nutritional 
factors.  However, it should be remembered that oral health was not specifically measured in this 
study and the cause of increase FLCs cannot be confirmed.  Associations between FLCs and oral 
health should be assessed in future studies.  Further, the relationship between FLCs in GCF and 
whole saliva, with and without inflammation, needs to be assessed to understand the mechanism 
behind these findings and their clinical consequences.  
 
Previous studies have shown alterations in immune parameters following short-term IT, and the 
current study extends these observations to FLCs.  Immune parameters have been shown to 
decrease with IT accompanied by a shift towards an anti-inflammatory immune profile, which has 
been implicated in increased risk of URTIs in athletes [19, 34, 35].  The increase in FLCs implies a 
local pro-inflammatory effect, suggesting that the oral environment may respond differently to IT.  
Another oral measure, SIgA, has been shown to decrease with IT and this has been associated 
with increased incidence of URTIs [19, 36, 37].  The balance between FLCs and SIgA may be 
indicative of oral inflammation vs mucosal defence, and would be interesting to investigate in 
relation to IT and infection incidence.  Further, oral health alongside immunity should be examined 
further in athletes, particularly during periods of IT: if oral health compromises local protection, this 
may be a mechanism/mediator of increased infection risk in athletes.  
The present study followed athletes over a relatively short time period (< 2 weeks) and it would be 
valuable to extend monitoring throughout cycles of training to see assess fluctuations in FLCs.  On 
return to normal training FLCs may return to baseline values, alternatively, continuation of IT may 
exacerbate elevations in FLCs.  When IT is sustained with an imbalance between training and 
recovery, non-functional over-reaching may occur, and, if prolonged further, athletes could develop 
overtraining syndrome, characterised by long-term impaired performance [1].  Currently there is a 
lack of biomarkers able to identify transitions between IT-non-functional over-reaching and 
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overtraining and those athletes at increased risk.  Low-grade systemic inflammation and immune 
dysregulation have been implicated as mediators in the development of overtraining syndrome [38, 
39].  However, immune parameters such as leukocyte counts, neutrophil function and SIgA levels 
are not strong predictors of overtraining [2].  Changes in FLCs with IT were proportionately greater 
in magnitude than those seen with acute exercise, one of the criteria for being able to monitor 
training states [1], although individual variability in responses was seen in this relatively small 
number of athletes.  For potential markers of training stress, it has been advised that individual 
profiles are obtained and samples are compared back to healthy baseline samples [2].  Thus in a 
future study, FLCs would need to be measured repeatedly in individuals over the course of the 
season to determine how FLCs respond to dynamics in training load to assess: firstly, if they are 
capable of sensitively detecting changes in training states, and secondly, if levels change prior to 
underperformance/ physiological or psychological symptoms as a potential prognostic marker of 
athletes at risk of entering states of non-functional overreaching or overtraining.  
The baseline TT did not result in any significant changes in saliva FLCs, although parameters were 
typically reduced post-exercise.  In contrast, after IT significant decreases in salivary FLCs were 
seen in response to the TT for concentrations, lambda secretion rate and FLC sum.  Interestingly, 
significant decreases in salivary FLCs have only been seen in older adults and not young adults 
previously [6], suggesting IT may make salivary FLCs more susceptible to the effects of acute 
exercise.  Changes in response to exercise are not explained by flow rate and may be due to 
changes in FLC transport into saliva with exercise; why this only occurs in response to exercise 
following IT is unclear.  If FLC transport is affected by blood flow, independently of saliva volume, 
then one possibility is that following IT a greater re-direction of circulation to the working muscles is 
required to sustain exercise performance.  Further, it remains to be seen how long salivary FLCs 
are reduced following exercise and if these changes have any implications for the health of 
athletes.  
In general, the serum parameters measured in this study did not significantly change following IT.  
Whole immunoglobulins decreased but reductions were generally small (< 6%).  Long-term 
intensive training has been associated with lower serum immunoglobulins in competitive athletes 
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compared to a moderately active control group [40].  Despite reductions in immunoglobulins 
following the short- term bout of IT, in the present study all immunoglobulin levels remained within 
the normal range and changes were not indicative of immunosuppression.  Serum creatinine 
levels, and thus eCrCl and eGFR, were unchanged suggesting that 9 days of IT does not impact 
upon renal function.  In addition, this study suggests that short-term IT does not significantly 
moderate responses to acute exercise for the serum parameters investigated: FLCs, IgG, IgA, IgM 
and creatinine.  
 
5. Conclusions  
In this study of trained cyclists, 9-days of IT increased resting salivary FLCs and amplified 
decreases in salivary FLCs in response to acute exercise.  This is the first study that has examined 
FLCs in relation to short-term IT and these findings suggest that salivary FLCs may be sensitive to 
changes in training load.  Increases in salivary FLCs likely reflect alterations in oral inflammation 
during times of heavy training.  Serum FLCs were unaffected by IT, signifying that increases in 
training volume and intensity only influenced FLCs at a local level.  The use of polyclonal FLCs in 
non-clinical populations and as a prognostic marker has emerged over the last 5 years.  The 
present study extends new research exploring FLCs in saliva highlighting their potential utility as a 
marker of exercise stress, or as an indirect marker of oral health, relevant to both athletes and the 
wider population.  Long-term studies over the training season and FLC assessments in parallel 
with oral health examinations are required to explore these possibilities.  
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  Fig 1  Salivary kappa (A) and lambda (B) free light chain (FLC) concentrations in response to a 1h 
cycling time trial in trained cyclists before and after a period of intensified training.   
A: ∗ Significant decrease in kappa FLC concentration post-exercise compared with pre-exercise, 
following intensified training only, p < .05.  B: † Significant elevation in pre-exercise lambda FLC 
levels post-intensified training compared with pre-intensified training, p < .05.  Serum FLC levels 
did not significantly change in response to acute exercise or intensified training   
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Fig 2  Salivary kappa (A) and lambda (B) free light chain (FLC) secretion rates in response to a 1h 
cycling time trial in trained cyclists before and after a period of intensified training  
A: ∗ Significant decrease in kappa FLC secretion rate post-exercise compared with pre-exercise, 
following intensified training only, p < .05.  B: ∗ Significant decrease in lambda FLC secretion rate 
post-exercise compared with pre-exercise, following intensified training only, p < .05    
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Fig 3.  Percentage changes in resting salivary kappa and lambda free light chain (FLC) 
concentration and secretion rates in response to a period of intensified training.  Boxes indicate the 
25–75th percentile, the line indicates the median and the whiskers represent the full range.  
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